Revenue and EBITDA declined year-over-year due to flooding and demerger costs, but cost savings and operational improvements are on track. H2 2025 is expected to see production recovery, with guidance maintained and capex reduced.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.